Mitochondrial‐targeted curcumin inhibits T‐cell activation via Nrf2 and inhibits graft‐versus‐host‐disease in a mouse model

Fuente: Wiley Open Access
Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Raghavendra S. Patwardhan, Dievya Gohil, Babita Singh, Binita K. Kumar, Vaitashi Purohit, Maikho Thoh, Rahul Checker, Nilesh Gardi, Vikram Gota, Vijay Kumar Kutala, Sejal Patwardhan, Deepak Sharma, Santosh K. Sandur
Format: Artículo Open Access
Veröffentlicht: Wiley 2024
Schlagworte:
Online-Zugang:
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
_version_ 1867003306418634752
author Raghavendra S. Patwardhan
Dievya Gohil
Babita Singh
Binita K. Kumar
Vaitashi Purohit
Maikho Thoh
Rahul Checker
Nilesh Gardi
Vikram Gota
Vijay Kumar Kutala
Sejal Patwardhan
Deepak Sharma
Santosh K. Sandur
author_facet Raghavendra S. Patwardhan
Dievya Gohil
Babita Singh
Binita K. Kumar
Vaitashi Purohit
Maikho Thoh
Rahul Checker
Nilesh Gardi
Vikram Gota
Vijay Kumar Kutala
Sejal Patwardhan
Deepak Sharma
Santosh K. Sandur
Raghavendra S. Patwardhan
Dievya Gohil
Babita Singh
Binita K. Kumar
Vaitashi Purohit
Maikho Thoh
Rahul Checker
Nilesh Gardi
Vikram Gota
Vijay Kumar Kutala
Sejal Patwardhan
Deepak Sharma
Santosh K. Sandur
collection Wiley Open Access
contents Mitochondrial‐targeted curcumin inhibits T‐cell activation via Nrf2 and inhibits graft‐versus‐host‐disease in a mouse model Raghavendra S. Patwardhan Dievya Gohil Babita Singh Binita K. Kumar Vaitashi Purohit Maikho Thoh Rahul Checker Nilesh Gardi Vikram Gota Vijay Kumar Kutala Sejal Patwardhan Deepak Sharma Santosh K. Sandur Phytotherapy Research AbstractAnti‐inflammatory and immune suppressive agents are required to moderate hyper‐activation of lymphocytes under disease conditions or organ transplantation. However, selective disruption of mitochondrial redox has not been evaluated as a therapeutic strategy for suppression of T‐cell‐mediated pathologies. Using mitochondrial targeted curcumin (MitoC), we studied the effect of mitochondrial redox modulation on T‐cell responses by flow cytometry, transmission electron microscopy, transcriptomics, and proteomics, and the role of Nrf2 was studied using Nrf2−/− mice. MitoC decreased mitochondrial TrxR activity, enhanced mitochondrial ROS (mROS) production, depleted mitochondrial glutathione, and suppressed activation‐induced increase in mitochondrial biomass. This led to suppression of T‐cell responses and metabolic reprogramming towards Treg differentiation. MitoC induced nuclear translocation and DNA binding of Nrf2, leading to upregulation of Nrf2‐dependent genes and proteins. MitoC‐mediated changes in mitochondrial redox and modulation of T‐cell responses are abolished in Nrf2−/− mice. Restoration of mitochondrial thiols abrogated inhibition of T‐cell responses. MitoC suppressed alloantigen‐induced lymphoblast formation, inflammatory cytokines, morbidity, and mortality in acute graft‐versus‐host disease mice. Disruption of mitochondrial thiols but not mROS increase inculcates an Nrf2‐dependent immune‐suppressive disposition in T cells for the propitious treatment of graft‐versus‐host disease. 10.1002/ptr.8126 http://onlinelibrary.wiley.com/termsAndConditions#vor
doi_str_mv 10.1002/ptr.8126
format Artículo Open Access
id wiley_oa_10_1002_ptr_8126
institution Wiley Open Access
license_str_mv http://onlinelibrary.wiley.com/termsAndConditions#vor
publishDate 2024
publisher Wiley
record_format wiley_oa
spellingShingle Mitochondrial‐targeted curcumin inhibits T‐cell activation via Nrf2 and inhibits graft‐versus‐host‐disease in a mouse model
Raghavendra S. Patwardhan
Dievya Gohil
Babita Singh
Binita K. Kumar
Vaitashi Purohit
Maikho Thoh
Rahul Checker
Nilesh Gardi
Vikram Gota
Vijay Kumar Kutala
Sejal Patwardhan
Deepak Sharma
Santosh K. Sandur
Phytotherapy Research
Mitochondrial‐targeted curcumin inhibits T‐cell activation via Nrf2 and inhibits graft‐versus‐host‐disease in a mouse model Raghavendra S. Patwardhan Dievya Gohil Babita Singh Binita K. Kumar Vaitashi Purohit Maikho Thoh Rahul Checker Nilesh Gardi Vikram Gota Vijay Kumar Kutala Sejal Patwardhan Deepak Sharma Santosh K. Sandur Phytotherapy Research AbstractAnti‐inflammatory and immune suppressive agents are required to moderate hyper‐activation of lymphocytes under disease conditions or organ transplantation. However, selective disruption of mitochondrial redox has not been evaluated as a therapeutic strategy for suppression of T‐cell‐mediated pathologies. Using mitochondrial targeted curcumin (MitoC), we studied the effect of mitochondrial redox modulation on T‐cell responses by flow cytometry, transmission electron microscopy, transcriptomics, and proteomics, and the role of Nrf2 was studied using Nrf2−/− mice. MitoC decreased mitochondrial TrxR activity, enhanced mitochondrial ROS (mROS) production, depleted mitochondrial glutathione, and suppressed activation‐induced increase in mitochondrial biomass. This led to suppression of T‐cell responses and metabolic reprogramming towards Treg differentiation. MitoC induced nuclear translocation and DNA binding of Nrf2, leading to upregulation of Nrf2‐dependent genes and proteins. MitoC‐mediated changes in mitochondrial redox and modulation of T‐cell responses are abolished in Nrf2−/− mice. Restoration of mitochondrial thiols abrogated inhibition of T‐cell responses. MitoC suppressed alloantigen‐induced lymphoblast formation, inflammatory cytokines, morbidity, and mortality in acute graft‐versus‐host disease mice. Disruption of mitochondrial thiols but not mROS increase inculcates an Nrf2‐dependent immune‐suppressive disposition in T cells for the propitious treatment of graft‐versus‐host disease. 10.1002/ptr.8126 http://onlinelibrary.wiley.com/termsAndConditions#vor
title Mitochondrial‐targeted curcumin inhibits T‐cell activation via Nrf2 and inhibits graft‐versus‐host‐disease in a mouse model
topic Phytotherapy Research
url https://onlinelibrary.wiley.com/doi/10.1002/ptr.8126